Constipation typically emerges during initial titration or after dose increases and often improves with continued treatment as the body adjusts
MeAgain is built for the daily GLP-1 journey: shot or pill timing, injection sites, food, protein, fiber, water, side effects, weight, progress photos, medication context, Journey Cards, and Capy
At therapeutic doses, typically 10 to 25 milligrams taken three times daily, it is generally well-tolerated and effective for mild to moderate nausea
Tirzepatide produces weight loss of 15% to 25% of body weight in clinical trials, far exceeding the threshold shown to improve sexual function
Why does non-selectivity limit its use as a research tool
It is safe and FDA-approved for Type 2 DM and weight loss